Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INTEGRA LIFESCIENCES HOLDINGS CORPORATION

(IART)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Integra LifeSciences : Q2 Adjusted Earnings, Revenue Rise; Issues Q3 Guidance, Updates Full-Year Outlook

07/28/2021 | 07:04am EDT


© MT Newswires 2021
All news about INTEGRA LIFESCIENCES HOLDINGS CORPORATION
09/15INTEGRA LIFESCIENCES : BTIG Downgrades Integra LifeSciences Holdings to Neutral ..
MT
09/07INSIDER SELL : Integra Lifesciences Holdings
MT
09/02INTEGRA LIFESCIENCES : Announces Participation in Upcoming Investor Conferences
AQ
08/10INSIDER TRENDS : 90-Day Insider Buying Trend at Integra LifeSciences Holdings Sl..
MT
07/29INTEGRA LIFESCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI..
AQ
07/29Tranche Update on Integra LifeSciences Holdings Corporation's Equity Buyback ..
CI
07/28INTEGRA LIFESCIENCES : Q2 Adjusted Earnings, Revenue Rise; Issues Q3 Guidance, U..
MT
07/28INTEGRA LIFESCIENCES : Reports Second Quarter 2021 Financial Results Raises Full..
PU
07/28INTEGRA LIFESCIENCES HOLDINGS CORP : Results of Operations and Financial Conditi..
AQ
07/28INTEGRA : Q2 Earnings Snapshot
AQ
More news
Analyst Recommendations on INTEGRA LIFESCIENCES HOLDINGS CORPORATION
More recommendations
Financials (USD)
Sales 2021 1 545 M - -
Net income 2021 157 M - -
Net Debt 2021 975 M - -
P/E ratio 2021 37,8x
Yield 2021 -
Capitalization 5 889 M 5 889 M -
EV / Sales 2021 4,44x
EV / Sales 2022 3,99x
Nbr of Employees 3 700
Free-Float 81,2%
Chart INTEGRA LIFESCIENCES HOLDINGS CORPORATION
Duration : Period :
Integra LifeSciences Holdings Corporation Technical Analysis Chart | IART | US4579852082 | MarketScreener
Technical analysis trends INTEGRA LIFESCIENCES HOLDINGS CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Last Close Price 69,63 $
Average target price 77,45 $
Spread / Average Target 11,2%
EPS Revisions
Managers and Directors
Peter J. Arduini President, Chief Executive Officer & Director
Carrie Anderson Chief Financial Officer, Treasurer & Executive VP
Stuart M. Essig Chairman
Kenneth E. Burhop Chief Scientific Officer & Vice President
William Compton Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
INTEGRA LIFESCIENCES HOLDINGS CORPORATION7.26%5 889
ABBOTT LABORATORIES15.80%224 776
MEDTRONIC PLC10.72%174 552
BECTON, DICKINSON AND COMPANY4.69%75 229
HOYA CORPORATION30.10%62 323
ALIGN TECHNOLOGY, INC.34.62%56 839